IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could enable physicians to detect diseases such as cancer before symptoms appear.
As reported today in the journal Nature Nanotechnology, the IBM team’s results show size-based separation of bioparticles down to 20 nanometers (nm) in diameter, a scale that gives access to important particles such as DNA, viruses and exosomes. Once separated, these particles can potentially be analyzed by physicians to reveal signs of disease even before patients experience any physical symptoms and when the outcome from treatment is most positive. Until now, the smallest bioparticle that could be separated by size with on-chip technologies was about 50 times or larger, for example, separation of circulating tumor cells from other biological components.
IBM is collaborating with a team from the Icahn School of Medicine at Mount Sinai to continue development of this lab-on-a-chip technology and plans to test it on prostate cancer, the most common cancer in men in the U.S.
In the era of precision medicine, exosomes are increasingly being viewed as useful biomarkers for the diagnosis and prognosis of malignant tumors. Exosomes are released in easily accessible bodily fluids such as blood, saliva or urine. They represent a precious biomedical tool as they can be used in the context of less invasive liquid biopsies to reveal the origin and nature of a cancer.
The IBM team targeted exosomes with their device as existing technologies face challenges for separating and purifying exosomes in liquid biopsies. Exosomes range in size from 20-140nm and contain information about the health of the originating cell that they are shed from. A determination of the size, surface proteins and nucleic acid cargo carried by exosomes can give essential information about the presence and state of developing cancer and other diseases.
exosomes of size 100 nm and larger could be separated from smaller exosomes, and that separation can take place in spite of diffusion, a hallmark of particle dynamics at these small scales. With Mt. Sinai, the team plans to confirm their device is able to pick up exosomes with cancer-specific biomarkers from patient liquid biopsies.
“The ability to sort and enrich biomarkers at the nanoscale in chip-based technologies opens the door to understanding diseases such as cancer as well as viruses like the flu or Zika,” said Gustavo Stolovitzky, Program Director of Translational Systems Biology and Nanobiotechnology at IBM Research. “Our lab-on-a-chip device could offer a simple, noninvasive and affordable option to potentially detect and monitor a disease even at its earliest stages, long before physical symptoms manifest. This extra amount of time allows physicians to make more informed decisions and when the prognosis for treatment options is most positive.”
Learn more:Â IBM Lab-on-a-Chip Breakthrough Aims to Help Physicians Detect Cancer
The Latest on: IBM Lab-on-a-Chip
[google_news title=”” keyword=”IBM Lab-on-a-Chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: IBM Lab-on-a-Chip
- IBM plots US$730 million expansion of Canadian semiconductor siteon April 26, 2024 at 8:20 am
INTERNATIONAL Business Machines will expand its Canadian semiconductor packaging and testing plant with more than C$1 billion (S$995 million) in investments over the next five years. Read more at The ...
- IBM Plots $730 Million Expansion of Canadian Semiconductor Siteon April 26, 2024 at 8:00 am
IBM’s C$1 billion Bromont growth plan will unfold between now and 2029, she confirmed. After months of talks with government, IBM will announce a C$227 million first phase on Friday to expand the ...
- Why IBM’s dazzling Watson supercomputer was a lousy tutoron April 26, 2024 at 2:00 am
With a new race underway to create the next teaching chatbot, IBM’s abandoned 5-year education push offers lessons about AI’s limits.
- Chip Industry Week In Reviewon April 26, 2024 at 12:01 am
U.S. workforce hubs; Samsung's V-NAND chip; TSMC's A16 process and SoW; NVIDIA's AI acquisitions; IBM to acquire HashiCorp; China/Japan AI EV partnerships; MIT's secure digital IMC chip; a foundry ...
- MIT Engineers Unveil Chip Boosting Smartphone AI and Security, Balancing Efficiency with Data Protectionon April 25, 2024 at 10:21 pm
MIT engineers developed a chip to protect personal data and enhance AI applications' efficiency in health-monitoring apps.
- ‘To the Future’: Saudi Arabia Spends Big to Become an A.I. Superpoweron April 24, 2024 at 9:00 pm
The oil-rich kingdom is plowing money into glitzy events, computing power and artificial intelligence research, putting it in the middle of an escalating U.S.-China struggle for technological ...
- This tiny chip can safeguard user data while enabling efficient computing on a smartphoneon April 23, 2024 at 3:56 pm
A new chip can efficiently accelerate machine-learning workloads on edge devices like smartphones while protecting sensitive user data from two common types of attacks -- side-channel attacks and ...
- MIT’s new powerful phone chip thwarts millions of data theft attacks in testson April 23, 2024 at 11:17 am
A team of researchers from MIT and the MIT-IBM Watson AI Lab has developed a new chip to make health-monitoring apps more secure. These new machine-learning accelerator chips aim to enhance data ...
- Intel completes assembly of world’s most advanced EUV lithography systemon April 19, 2024 at 10:07 am
Intel Corp.’s newly formed chip foundry business said today it has achieved a crucial milestone for the chipmaking industry by completing the assembly of the world’s first commercial High Numerical ...
- Intel builds world’s largest neuromorphic systemon April 17, 2024 at 10:22 pm
Intel's newest neuromorphic computer is deployed at Sandia National Laboratories. Code-named Hala Point, the brain-inspired system packs 1,152 Loihi 2 processors in a data center chassis the size of a ...
via Bing News